Ocular Therapeutix, Inc. (OCUL)

10.78 -0.20 (-1.87%) USD  |  NASDAQ  |  Mar 03, 16:00
10.67 -0.10 (-0.97%) After-Hours: 20:00
More

Ocular Therapeutix Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Abbott Laboratories Upgrade
EyePoint Plc Upgrade
Quince Therapeutics, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade